DURECT Corporation
NASDAQ:DRRX
1.35 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | DURECT Corporation |
Symbool | DRRX |
Munteenheid | USD |
Prijs | 1.35 |
Beurswaarde | 41,903,190 |
Dividendpercentage | 0% |
52-weken bereik | 0.47 - 2.77 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. James E. Brown D.V.M. |
Website | https://www.durect.com |
An error occurred while fetching data.
Over DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)